BioSpace News Archive

One of the U.S. Food and Drug Administration’s top priorities is to ensure that Americans have access to safe and effective medicines

ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Paterson, New Jersey.

Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has announced the completion of its latest success story that highlights how ‘Patient Journey Mapping Helped a Pharma Company to Uncover New Insights and Explore Future Growth Opportunities Within the Cardiovascular Drugs Segment.’

Upsher-Smith Laboratories, LLC is pleased to announce Steve Moore, PharmD, who along with his family, owns Condo Pharmacy in Plattsburgh, New York as the winner of the 2019 National Community Pharmacist Association Independent Pharmacist of the Year award.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Medtronic Fully Implantable Left Ventricular Assist Device (LVAD) for patients with advanced heart failure, currently in development.

NeoDynamics today received confirmation from Intertek (Notified Body) that the improved version of the new system for breast cancer biopsy, NeoNavia, is accepted as an update to the already EU approved study version.

October may be National Breast Cancer Awareness month, but at Margaret West Comprehensive Breast Center, our breast team is working every day of every month to identify, prevent, and treat breast cancer.

Marina Maher Communications (MMC) announced the appointment of Jennifer O’Neill to Managing Director Healthcare, overseeing its two healthcare groups: MMC Health & Well-Being and RXMOSAIC.

Absorption Systems, a global leader in translational medicine, pharmacokinetic testing of drugs, and cell and gene therapy, announces that it has been awarded a 2-year contract for a total amount of approximately $300,000 by the U.S. Food and Drug Administration (FDA).

Blink Health, the digital health company on a mission to make prescription drugs affordable for everyone, has appointed Kathy Reardon as Chief Healthcare Counsel. Reardon joins the company with two decades of experience navigating the legal intricacies of the complex and opaque pharmaceutical supply chain.